The American Society of Gene and Cell Therapy's (ASGCT) Annual Meeting, is the premier event for professionals in gene and cell therapy. It is the best place for people in the field to learn from the latest scientific research, stay up to date on new technologies, and make career-advancing connections with peers.
At MaxCyte, we take a collaborative approach with our clients to rapidly drive their developmental efforts from research forward to commercialization, safely, and cost-effectively. We partner with cutting-edge academic institutions, translational centers, and biopharmaceutical businesses by providing access to our scalable cell-engineering platform.
With our best-in-class delivery system, our team of scientific experts helps our collaborators unlock the potential of their products by solving development and commercialization challenges. This session will feature success stories from two of our client advocates, Dr. Jonathan Yen and Dr. Alicja Copik. Their talks will showcase MaxCyte's focus on high-performance cellular editing and our outstanding technical support to enable our customers to use a single unifying technology, from concept to clinic.